Chroma Medicine is a biotechnology company pioneering a new class of genomic medicines that harness epigenetics, nature's innate mechanism for gene regulation, to deliver precise, programmable single-dose therapeutics while preserving genomic integrity. The company was founded by the world's foremost experts in genomic research and is led by a veteran team of industry leaders and scientists with deep experience in genomic medicine, drug discovery, and development.

Key Contact

Funding Events

Date	Amount	Type	Investors	Valuation
03/01/23	$135,000,000	Series B	Alexandria Venture Investments ARCH Venture Partners Atlas Venture Casdin Capital Cormorant Asset Management DCVC Bio GV Janus Henderson Investors Mubadala Capital Newpath Partners Omega Funds Osage University Partners Sixth Street Sofinna Partners T. Rowe Price Associates Wellington Management	undisclosed